Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 clinical trial evaluating intravenous infusion of allogeneic mesenchymal stem cells deriv…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Dyspnea and Idiopathic Pulmonary Fibrosis
A clinical trial investigating dyspnea in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: MRI Quantification of Pulmonary Fibrosis in Scleroderma Patients [NA]
A completed clinical trial evaluating MRI-based quantification of pulmonary fibrosis in patients with systemic sclerosis (scleroderma) to as…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure [Phase 1]
This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of inhaled CHF10073 in healthy volunteers, including the effect …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
A clinical trial evaluating inspiratory effort via nasal pressure measurement in patients with idiopathic pulmonary fibrosis is currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome [NA]
This update reports the completion of a genetics study on Combined Pulmonary Fibrosis and Emphysema Syndrome. The study appears to have incl…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics of the investigational drug 9MW3811 in healthy subjects has completed. It…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: AI Assisted Detection of Chest X-Rays
A completed clinical trial evaluated an AI-assisted chest X-ray detection system. The study covered various thoracic conditions including pu…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies [Phase 2]
Phase 2 pilot study evaluating pirfenidone in pulmonary fibrosis with anti-myeloperoxidase antibodies has completed. The update notes the tr…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects [Phase 1]
Phase 1 trial evaluating potential drug interactions among HRS-9813, pirfenidone, and nintedanib in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)
A clinical trial examining frequency-time analysis of pathological lung sounds in patients with cystic fibrosis, pulmonary fibrosis, or chro…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study
The RESPIFLU study (NCT01271842) reports long-term outcomes and lung capacity in survivors of acute respiratory distress syndrome due to inf…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Automated Oxygen Titration During Walking in Patients With Lung Fibrosis (OXYWILD) [NA]
This entry notes the completed clinical trial OXYWILD evaluating automated oxygen titration during walking in patients with pulmonary fibros…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis [Phase 2]
The Phase 2 TELO-SCOPE study evaluating danazol to attenuate telomere attrition in pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects [Phase 1]
Phase 1 trial update reports completion of a study evaluating HRS-9813 capsules and tablets in healthy subjects, with pulmonary fibrosis ref…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: FAPI PET for Lung Fibrosis [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating FAPI PET imaging for interstitial lung disease and pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis [NA]
A completed clinical trial assessing the effectiveness of pulmonary rehabilitation on oxygen saturation in patients with idiopathic pulmonar…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Longidaza for residual lung changes after COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Interstitial Lung Disease Exacerbations Study
Clinical trial update for an interstitial lung disease/exacerbations study sponsored by Royal Devon and Exeter NHS Foundation Trust. The tri…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis
This completed clinical trial evaluates metabolomic biomarkers in pulmonary fibrosis; no results on treatments or efficacy are provided in t…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital [Phase 3]
A Phase 3 clinical trial evaluating safety and effectiveness of cyclosporin for managing COVID-19 acute respiratory distress syndrome has co…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis [NA]
A completed clinical trial comparing pulmonary telerehabilitation to standard physical activity recommendations in patients with post-COVID …
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 [Phase 1]
A Phase 1 trial evaluating the imaging agent 68Ga-FAP-2286 for pathologic fibrosis in liver, lung, and heart has completed its Phase 1 study…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device [NA]
A completed clinical trial in people with pulmonary fibrosis to monitor cough using a wearable device; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating BMS-986278 in patients with pulmonary fibrosis has completed, and its results have been posted.